|
|
||||||||
in the Pathogenesis of a Murine Systemic Candida albicans Infection
Department of Preclinical Research and Development, Genetics Institute, Inc., Andover, MA 01810
Studies on murine candidiasis suggest that resistance to disease is
linked to a Th1 response and production of IFN-
, while failure to
elicit protection is associated with a Th2 response and production of
IL-4 and IL-10. Experimental infection of C57BL/6 mice, IL-12 treatment
of these mice, or both infection and IL-12 treatment resulted in a
characteristic Th1 cytokine mRNA profile as measured by quantitative
competitive PCR. Specifically, little or no IL-4 transcripts were
detected, while IFN-
message was elevated, particularly with IL-12
treatment. Despite its role in driving increased IFN-
expression and
production, IL-12 treatment, paradoxically, promoted disease
progression in our model. Therefore, we examined the effect of IFN-
neutralization on IL-12-induced susceptibility to infection. None of
the systemically infected mice receiving IL-12 alone survived, while
IL-12- and anti-IFN-
-treated mice had a 70% survival rate,
similar to that after infection alone. These results suggested that
IFN-
induced by IL-12 treatment contributed to lethality. However,
in separate studies, IFN-
knockout mice were more susceptible to
infection than their wild-type counterparts, suggesting that IFN-
is
required for resistance. Nonetheless, infected IFN-
knockout mice
treated with recombinant murine IL-12 exhibited enhanced resistance,
suggesting that the toxicities observed with IL-12 are directly
attributable to IFN-
and that an optimal immune response to
Candida infections necessitates a finely tuned balance of
IFN-
production. Thus, we propose that although IFN-
can drive
resistance, the overproduction of IFN-
during candidiasis, mediated
by IL-12 administration, leads to enhanced susceptibility.
This article has been cited by other articles:
![]() |
J. Hu, Y. Wang, and L. Xie Potential Role of Macrophages in Experimental Keratomycosis Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2087 - 2094. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ito, J. Pedras-Vasconcelos, and D. M. Klinman CpG Oligodeoxynucleotides Increase the Susceptibility of Normal Mice to Infection by Candida albicans Infect. Immun., September 1, 2005; 73(9): 6154 - 6156. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Lindell, T. A. Moore, R. A. McDonald, G. B. Toews, and G. B. Huffnagle Generation of Antifungal Effector CD8+ T Cells in the Absence of CD4+ T Cells during Cryptococcus neoformans Infection J. Immunol., June 15, 2005; 174(12): 7920 - 7928. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bozza, F. Fallarino, L. Pitzurra, T. Zelante, C. Montagnoli, S. Bellocchio, P. Mosci, C. Vacca, P. Puccetti, and L. Romani A Crucial Role for Tryptophan Catabolism at the Host/Candida albicans Interface J. Immunol., March 1, 2005; 174(5): 2910 - 2918. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zafirova, M. Yordanov, and R. Kalfin Antiarthritic effect of VIP in relation to the host resistance against Candida albicans infection Int. Immunol., August 1, 2004; 16(8): 1125 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Sandler, M. M. Mentink-Kane, A. W. Cheever, and T. A. Wynn Global Gene Expression Profiles During Acute Pathogen-Induced Pulmonary Inflammation Reveal Divergent Roles for Th1 and Th2 Responses in Tissue Repair J. Immunol., October 1, 2003; 171(7): 3655 - 3667. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koido, Y. Tanaka, D. Chen, D. Kufe, and J. Gong The Kinetics of In Vivo Priming of CD4 and CD8 T Cells by Dendritic/Tumor Fusion Cells in MUC1-Transgenic Mice J. Immunol., March 1, 2002; 168(5): 2111 - 2117. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chiani, C. Bromuro, and A. Torosantucci Defective Induction of Interleukin-12 in Human Monocytes by Germ-Tube Forms of Candida albicans Infect. Immun., October 1, 2000; 68(10): 5628 - 5634. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Elahi, G. Pang, R. Clancy, and R. B. Ashman Cellular and Cytokine Correlates of Mucosal Protection in Murine Model of Oral Candidiasis Infect. Immun., October 1, 2000; 68(10): 5771 - 5777. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |